Profil
Dr. Michael Schirner, MD, is a Managing Director at mivenion GmbH.
Dr. Schirner was previously employed as a Principal by Schering AG.
He received his undergraduate degree from the Friedrich Schiller University of Jena and a doctorate degree from Martin-Luther-Universität Halle-Wittenberg.
Anciens postes connus de Michael Schirner
| Sociétés | Poste | Fin |
|---|---|---|
| Bayer Schering Pharma AG | Corporate Officer/Principal | 01/01/2007 |
mivenion GmbH
 mivenion GmbH Medical SpecialtiesHealth Technology mivenion GmbH offers personalized medical solutions for patients with inflammatory and autoimmune diseases. Its flagship product, Xiralite, enables the Rheumascan procedure that provides integrated solution for patients with inflammatory diseases in the hands. The company was founded by Michael Schirner and Malte Bahner in 2007 and is headquartered in Berlin, Germany. | Directeur Général | - |
Formation de Michael Schirner
| Friedrich Schiller University of Jena | Undergraduate Degree |
| Martin-Luther-Universität Halle-Wittenberg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
mivenion GmbH
mivenion GmbH Medical SpecialtiesHealth Technology mivenion GmbH offers personalized medical solutions for patients with inflammatory and autoimmune diseases. Its flagship product, Xiralite, enables the Rheumascan procedure that provides integrated solution for patients with inflammatory diseases in the hands. The company was founded by Michael Schirner and Malte Bahner in 2007 and is headquartered in Berlin, Germany. | Health Technology |
| Bayer Schering Pharma AG | Health Technology |
